A newly discovered biomarker in spinal fluid can diagnose Parkinson’s and Lewy body dementia with over 90% accuracy, potentially ending frequent misdiagnoses between these conditions and Alzheimer’s.
Most Recent Articles
AI-Driven Quantification of Cutaneous Mastocytosis Response to Avapritinib
Researchers are using artificial intelligence to prove that a new drug reduces mastocytosis skin lesions by over 36%, offering a more precise way to measure treatment success.
Differentiating Biological Drivers from Chronological Bystanders in Human Aging
A new European study uses 10 specific blood biomarkers to calculate a person’s "biological age," revealing why some people stay physiologically younger than their chronological age.
Demographic Distribution and Cognitive Dysfunction Trends in Long COVID Patients
New research estimates that long COVID affects up to 400 million people globally, causing significant cognitive impairment and an annual economic loss of approximately $1 trillion.
Strategic Recommendations for Modernizing Radiation Safety in Fluoroscopic Settings
Medical experts are calling for a new "ALARA+" safety standard to protect interventional teams from the combined dangers of radiation exposure and heavy lead-induced orthopedic injuries.